These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9584044)

  • 21. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients].
    Yokosuka K; Teshima H; Katase K; Fujimoto I; Yamauchi K; Hasumi K; Tatsuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):125-32. PubMed ID: 7706853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
    Kennedy MM; Baigrie CF; Manek S
    Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
    Rieck GC; Freites ON; Williams S
    J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of tamoxifen on the uterus.
    Ismail SM
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tamoxifen and endometrial disease in patients with breast cancer].
    Dalbert DB; Rodríguez de la Peña MM; Figueredo A; Mural J; Bartt O; Subiela R; Rossi C; Bazán G
    Medicina (B Aires); 2013; 73(2):97-103. PubMed ID: 23570756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
    BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
    Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
    Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment.
    Marchesoni D; Driul L; Mozzanega B; Nardelli GB; Parenti A
    Arch Gynecol Obstet; 2005 Jan; 271(1):62-5. PubMed ID: 15290168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
    Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.